TLGT - FDA approves Teligent's clobetasol propionate ointment; shares up 12% premarket January, 24 2019 09:26 AM Teligent Inc. The FDA has approved Teligent's (NASDAQ:TLGT) abbreviated new drug application (ANDA) of Clobetasol Propionate Ointment USP, 0.05%. More news on: Teligent, Inc., Healthcare stocks news, Stocks on the move, Read more ...